Harel Insurance Investments & Financial Services’s Abiomed Inc ABMD Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-500	Closed	-$521K	–	912
2020 Q4	$521K	Buy	+500	New	+$138K	0.01%	360
2020 Q3	–	Sell	-930	Closed	-$225K	–	740
2020 Q2	$225K	Buy	+930	New	+$187K	0.01%	236
2020 Q1	–	Sell	-226	Closed	-$39K	–	549
2019 Q4	$39K	Buy	226 +173	+326%	+$32.1K	﹤0.01%	372
2019 Q3	$9K	Hold	53	–	–	﹤0.01%	457
2019 Q2	$14K	Sell	53 -16	-23%	-$4.25K	﹤0.01%	405
2019 Q1	$19K	Sell	69 -333	-83%	-$111K	﹤0.01%	370
2018 Q4	$131K	Buy	402 +281	+232%	+$97.6K	0.01%	213
2018 Q3	$53K	Buy	121 +8	+7%	+$3.15K	﹤0.01%	334
2018 Q2	$46K	Buy	+113	New	+$40.9K	﹤0.01%	303

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Harel Insurance Investments & Financial Services's ABMD Position: Q1 2021 in Review

Harel Insurance Investments & Financial Services sold out of Abiomed Inc (ABMD) in Q1 2021, closing a stake of 500 shares — an estimated $521K sold.

Harel Insurance Investments & Financial Services first reported a position in ABMD in Q2 2018 and held it in 9 quarters. The position peaked at $521K in Q4 2020. 487 funds tracked by Wall St. Rank hold ABMD as of Q1 2021.

Harel Insurance Investments & Financial Services reported no remaining Abiomed Inc position as of Q1 2021 after selling out during the quarter.
Harel Insurance Investments & Financial Services sold 500 Abiomed Inc shares in Q1 2021, an estimated $521K.
Harel Insurance Investments & Financial Services first reported a position in Abiomed Inc in Q2 2018 and held it in 9 quarters.
Harel Insurance Investments & Financial Services's Abiomed Inc position peaked at $521K in Q4 2020.
487 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2021.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q1 2021, filed 27 Apr 2021.